DE602005003315D1 - BenzoÄbÜpyranoÄ3,2-hÜacridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltend - Google Patents

BenzoÄbÜpyranoÄ3,2-hÜacridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltend

Info

Publication number
DE602005003315D1
DE602005003315D1 DE602005003315T DE602005003315T DE602005003315D1 DE 602005003315 D1 DE602005003315 D1 DE 602005003315D1 DE 602005003315 T DE602005003315 T DE 602005003315T DE 602005003315 T DE602005003315 T DE 602005003315T DE 602005003315 D1 DE602005003315 D1 DE 602005003315D1
Authority
DE
Germany
Prior art keywords
alkyl
aryl
optionally substituted
halo
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005003315T
Other languages
English (en)
Other versions
DE602005003315T2 (de
Inventor
Michel Koch
Francois Tillequin
Sylvie Michel
John Hickman
Alain Pierre
Stephane Leonce
Bruno Pfeiffer
Laurence Kraus-Berthier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Paris 5 Rene Descartes
Laboratoires Servier SAS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Paris 5 Rene Descartes
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Paris 5 Rene Descartes, Laboratoires Servier SAS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE602005003315D1 publication Critical patent/DE602005003315D1/de
Application granted granted Critical
Publication of DE602005003315T2 publication Critical patent/DE602005003315T2/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DE602005003315T 2004-12-22 2005-12-21 BenzoÄbÜpyranoÄ3,2-hÜacridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltend Expired - Fee Related DE602005003315T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0413682 2004-12-22
FR0413682A FR2879600B1 (fr) 2004-12-22 2004-12-22 Nouveaux derives cinnamates de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE602005003315D1 true DE602005003315D1 (de) 2007-12-27
DE602005003315T2 DE602005003315T2 (de) 2008-09-25

Family

ID=34954114

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005003315T Expired - Fee Related DE602005003315T2 (de) 2004-12-22 2005-12-21 BenzoÄbÜpyranoÄ3,2-hÜacridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltend

Country Status (26)

Country Link
US (1) US7144891B2 (de)
EP (1) EP1674101B1 (de)
JP (1) JP2006176525A (de)
KR (1) KR100742060B1 (de)
CN (1) CN1796387A (de)
AT (1) ATE378050T1 (de)
AU (1) AU2005247032A1 (de)
BR (1) BRPI0506019A (de)
CA (1) CA2529630A1 (de)
CY (1) CY1107100T1 (de)
DE (1) DE602005003315T2 (de)
DK (1) DK1674101T3 (de)
EA (1) EA010094B1 (de)
ES (1) ES2297648T3 (de)
FR (1) FR2879600B1 (de)
HR (1) HRP20070524T3 (de)
MA (1) MA27965A1 (de)
MX (1) MXPA05013993A (de)
MY (1) MY138045A (de)
NO (1) NO20056091L (de)
NZ (1) NZ544315A (de)
PL (1) PL1674101T3 (de)
PT (1) PT1674101E (de)
SG (1) SG123675A1 (de)
SI (1) SI1674101T1 (de)
ZA (1) ZA200510323B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902792A1 (fr) * 2006-06-21 2007-12-28 Servier Lab Nouveaux derives cinnamates de tetrahydro-7h-pyrano(2,3-c)acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772765B1 (fr) * 1997-12-19 2000-03-17 Adir Nouveaux derives de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2795071B1 (fr) * 1999-06-16 2001-07-27 Adir Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7056929B2 (en) * 2001-07-25 2006-06-06 Les Laboratoires Servier Benzo[b]pyrano[3,2-h]acridin-7-one compounds
FR2827864B1 (fr) * 2001-07-25 2005-09-16 Servier Lab Nouveaux derives de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
DE602005003315T2 (de) 2008-09-25
ATE378050T1 (de) 2007-11-15
US20060135545A1 (en) 2006-06-22
CA2529630A1 (fr) 2006-06-22
PL1674101T3 (pl) 2008-05-30
EA200501845A3 (ru) 2006-10-27
NZ544315A (en) 2006-11-30
HRP20070524T3 (en) 2008-07-31
EA200501845A2 (ru) 2006-06-30
NO20056091L (no) 2006-06-23
BRPI0506019A (pt) 2006-09-19
JP2006176525A (ja) 2006-07-06
EA010094B1 (ru) 2008-06-30
KR20060072093A (ko) 2006-06-27
MA27965A1 (fr) 2006-07-03
CY1107100T1 (el) 2012-10-24
CN1796387A (zh) 2006-07-05
DK1674101T3 (da) 2008-03-03
ZA200510323B (en) 2006-12-27
SI1674101T1 (sl) 2008-04-30
EP1674101B1 (de) 2007-11-14
MY138045A (en) 2009-04-30
ES2297648T3 (es) 2008-05-01
EP1674101A1 (de) 2006-06-28
AU2005247032A1 (en) 2006-07-06
US7144891B2 (en) 2006-12-05
KR100742060B1 (ko) 2007-07-23
FR2879600B1 (fr) 2007-02-09
PT1674101E (pt) 2007-12-17
MXPA05013993A (es) 2006-06-21
FR2879600A1 (fr) 2006-06-23
SG123675A1 (en) 2006-07-26

Similar Documents

Publication Publication Date Title
DE69828445D1 (de) Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
BR0008770A (pt) Derivado de pirimidina, processo para a preparação de um derivado de pirimidina, processo para a produção de um efeito anti-câncer em um animal de sangue quente, uso de um derivado de pirimidina, e, composição farmacêutica
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
BR0317294A (pt) Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com a glicogênio sintase quinase-3 e de prevenção e/ou tratamento de doenças, e, uso dos intermediários
RS49850B (sr) Derivati 1,4-benzotiazepin-1,1-dioksida supstituisani radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
BR0308056A (pt) Composto, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto
NO20085078L (no) Nye forbindelser
BRPI0407506A (pt) compostos para o tratamento de distúrbios metabólicos, seu uso e composição farmacêutica compreendendo os mesmos
AR005827A1 (es) Compuesto derivado de nucleosidos aciclicos, composicion farmaceutica que lo comprende, uso del mismo en la preparacion de un medicamento y su metodo de preparacion
ATE10804T1 (de) Ein diphenylhydantoin-derivat enthaltende pharmazeutische zusammensetzung, verwendete derivate und ihre herstellung.
NO20044810L (no) Farmasoytisk formulering med oyeblikkelig frigjoring
AR036176A1 (es) Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
HUT59124A (en) Process for producing 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
DE602005003315D1 (de) BenzoÄbÜpyranoÄ3,2-hÜacridin-7-one-zimtsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen diese enthaltend
BG106520A (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
BR9917315A (pt) Composições medicinais para liberação imediata para uso oral
MX9405111A (es) Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina).
WO2001017955A3 (en) Hydroxyacetamidobenzenesulphonamide derivatives
AR020294A1 (es) COMPUESTOS DERIVADOS DE 1-TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL-AMINOMETILCROMANO, COMPOSICION FARMACEUTICA Y USO EN LA PREPARACIoN DE MEDICAMENTOS.
AR046212A1 (es) Derivados de 2-fenilbenzofurano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
RU97102333A (ru) Производные диарилалканов, содержащие алициклическую группу, их получение и терапевтическое и профилактическое применение
NO20002315L (no) Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
SE8903313L (sv) Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem
DE3168174D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee